• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同阶段乳腺病变旁健康组织中雌激素和孕激素受体的分布——107例免疫组织化学研究

Distribution of estrogen and progesterone receptors in healthy tissue adjacent to breast lesions at various stages--immunohistochemical study of 107 cases.

作者信息

Jacquemier J D, Hassoun J, Torrente M, Martin P M

机构信息

Institut J. Paoli, I. Calmettes, Marseille, France.

出版信息

Breast Cancer Res Treat. 1990 Feb;15(2):109-17. doi: 10.1007/BF01810783.

DOI:10.1007/BF01810783
PMID:2322649
Abstract

The purpose of this study was to determine the distribution of ER+ (estrogen receptor) and PR+ (progesterone receptor) epithelial cells in normal mammary tissue or in tissue in contact with or involved in benign or malignant processes. Three important findings emerged from this study. First, a true dissociation was observed between ER+ and PR+ cells in mammary tissue. In premenopausal women some cells express only progesterone receptors. In premenopausal normal tissue, regardless of the menstrual cycle status, 6% of cells are ER+ and 29% PR+. Second, during the menstrual cycle the percentage of positive cells varies. This finding would indicate a change in cell recruitment rather than in intracellular levels. Finally, specific changes in the proportion of positive cells in normal tissue in contact with epithelial proliferations were noted. This finding suggests the possibility of either a diffusible factor or a cellular pathological process spreading beyond areas displaying morphological changes.

摘要

本研究的目的是确定雌激素受体(ER+)和孕激素受体(PR+)上皮细胞在正常乳腺组织、或与良性或恶性病变相关或受其累及的组织中的分布情况。该研究有三项重要发现。首先,在乳腺组织中观察到ER+和PR+细胞之间存在真正的分离。在绝经前女性中,一些细胞仅表达孕激素受体。在绝经前正常组织中,无论月经周期状态如何,6%的细胞为ER+,29%为PR+。其次,在月经周期中,阳性细胞的百分比会发生变化。这一发现表明是细胞募集发生了变化,而非细胞内水平改变。最后,观察到与上皮增生相关的正常组织中阳性细胞比例有特定变化。这一发现提示,可能存在一种可扩散因子,或者一种细胞病理过程,其扩散范围超出了显示形态学变化的区域。

相似文献

1
Distribution of estrogen and progesterone receptors in healthy tissue adjacent to breast lesions at various stages--immunohistochemical study of 107 cases.不同阶段乳腺病变旁健康组织中雌激素和孕激素受体的分布——107例免疫组织化学研究
Breast Cancer Res Treat. 1990 Feb;15(2):109-17. doi: 10.1007/BF01810783.
2
Comparison of an immunocytochemical assay for progesterone receptor with a biochemical method of measurement and immunocytochemical examination of the relationship between progesterone and estrogen receptors.孕酮受体免疫细胞化学检测法与生化测量方法的比较以及孕酮与雌激素受体关系的免疫细胞化学检查
Cancer Res. 1989 Sep 15;49(18):5176-9.
3
Estrogen and progesterone receptors in benign breast tumors and lesions: relationship with histological and cytological features.良性乳腺肿瘤和病变中的雌激素和孕激素受体:与组织学和细胞学特征的关系。
Int J Cancer. 1986 Jan 15;37(1):7-10. doi: 10.1002/ijc.2910370103.
4
Survival of premenopausal breast carcinoma patients in relation to menstrual cycle timing of surgery and estrogen receptor/progesterone receptor status of the primary tumor.绝经前乳腺癌患者的生存情况与手术时的月经周期时间及原发肿瘤的雌激素受体/孕激素受体状态的关系。
Cancer. 1999 Nov 15;86(10):2053-8. doi: 10.1002/(sici)1097-0142(19991115)86:10<2053::aid-cncr24>3.0.co;2-h.
5
Elastosis and steroid receptors in primary breast cancer.原发性乳腺癌中的弹性组织变性与类固醇受体
Braz J Med Biol Res. 1985;18(3):279-83.
6
Lactate dehydrogenase in breast carcinoma: correlation with estrogen and progesterone receptors.乳腺癌中的乳酸脱氢酶:与雌激素和孕激素受体的相关性
Cancer Detect Prev. 1983;6(1-2):241-7.
7
Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.人乳腺癌中雌激素、孕激素、雄激素和糖皮质激素受体的分布、频率及定量分析。
Cancer Res. 1979 May;39(5):1447-54.
8
Influence of the menstrual cycle on the concentrations of estrogen and progesterone receptors in primary breast cancer biopsies.月经周期对原发性乳腺癌活检组织中雌激素和孕激素受体浓度的影响。
Breast Cancer Res Treat. 1988 Apr;11(1):45-50. doi: 10.1007/BF01807557.
9
Human breast tumors: a comparison between the biochemical method of measuring estrogen and progesterone receptors and that of an immunohistochemical method.人类乳腺肿瘤:测量雌激素和孕激素受体的生化方法与免疫组化方法的比较。
Gynecol Oncol. 1989 Feb;32(2):174-9. doi: 10.1016/s0090-8258(89)80029-0.
10
[Relationship of estrogen and progesterone receptors to the menstrual cycle and menopausal status at the time of breast surgery].[雌激素和孕激素受体与乳房手术时月经周期及绝经状态的关系]
Zentralbl Gynakol. 1999;121(8):367-74.

引用本文的文献

1
Morphological Features and Immunohistochemical Profiling of Male Breast Gynaecomastia; A Large Tissue Microarray Study.男性乳腺增生症的形态学特征及免疫组织化学分析;一项大型组织芯片研究
Front Oncol. 2022 Jun 23;12:875839. doi: 10.3389/fonc.2022.875839. eCollection 2022.
2
Investigating the Factors Associated with the Level of Expression of Estrogen and Progesterone Receptors in Patients Suffering from Colorectal Cancer.探究结直肠癌患者雌激素和孕激素受体表达水平的相关因素。
J Cancer Epidemiol. 2021 Oct 15;2021:4478155. doi: 10.1155/2021/4478155. eCollection 2021.
3
Protein arginine N-methyltransferase 2 reverses tamoxifen resistance in breast cancer cells through suppression of ER-α36.

本文引用的文献

1
Estradiol and progesterone receptors in human breast fibroadenomas.人乳腺纤维腺瘤中的雌二醇和孕酮受体
J Clin Endocrinol Metab. 1981 Jun;52(6):1225-9. doi: 10.1210/jcem-52-6-1225.
2
Variant T47D human breast cancer cells with high progesterone-receptor levels despite estrogen and antiestrogen resistance.具有高孕酮受体水平的变异型T47D人乳腺癌细胞,尽管对雌激素和抗雌激素有抗性。
Cell. 1982 Mar;28(3):633-42. doi: 10.1016/0092-8674(82)90218-5.
3
Progestin and oestrogen receptors in meningiomas. Biochemical characterization, clinical and pathological correlations in 42 cases.
蛋白精氨酸 N-甲基转移酶 2 通过抑制 ER-α36 逆转乳腺癌细胞对他莫昔芬的耐药性。
Oncol Rep. 2018 Jun;39(6):2604-2612. doi: 10.3892/or.2018.6350. Epub 2018 Apr 2.
4
Breast cancer risk factors in relation to estrogen receptor, progesterone receptor, insulin-like growth factor-1 receptor, and Ki67 expression in normal breast tissue.正常乳腺组织中雌激素受体、孕激素受体、胰岛素样生长因子-1受体及Ki67表达与乳腺癌风险因素的关系
NPJ Breast Cancer. 2017 Oct 2;3:39. doi: 10.1038/s41523-017-0041-7. eCollection 2017.
5
Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer.正常风险或高风险乳腺癌女性正常乳腺组织中的基因组变化。
Breast Cancer (Auckl). 2016 Aug 17;10:109-46. doi: 10.4137/BCBCR.S39384. eCollection 2016.
6
Histopathological Features of Non-Neoplastic Breast Parenchyma Do Not Predict BRCA Mutation Status of Patients with Invasive Breast Cancer.非肿瘤性乳腺实质的组织病理学特征不能预测浸润性乳腺癌患者的BRCA突变状态。
Biomark Cancer. 2015 Aug 18;7:39-49. doi: 10.4137/BIC.S29716. eCollection 2015.
7
Systems level-based RNAi screening by high content analysis identifies UBR5 as a regulator of estrogen receptor-α protein levels and activity.基于系统水平的RNA干扰筛选通过高内涵分析鉴定出UBR5作为雌激素受体α蛋白水平和活性的调节因子。
Oncogene. 2015 Jan 8;34(2):154-64. doi: 10.1038/onc.2013.550. Epub 2014 Jan 20.
8
Model of tumor-associated epigenetic changes of HER2, ER, and PgR expression in invasive breast cancer phenotypes.
Tumour Biol. 2013 Aug;34(4):2011-7. doi: 10.1007/s13277-013-0809-9. Epub 2013 May 3.
9
Lowering oral contraceptive norethindrone dose increases estrogen and progesterone receptor levels with no reduction in proliferation of breast epithelium: a randomized trial.降低口服避孕药左炔诺孕酮剂量会增加雌激素和孕激素受体水平,而不会减少乳腺上皮细胞的增殖:一项随机试验。
Contraception. 2012 Sep;86(3):238-43. doi: 10.1016/j.contraception.2011.12.015. Epub 2012 Feb 9.
10
Anti-tumor effects of retinoids combined with trastuzumab or tamoxifen in breast cancer cells: induction of apoptosis by retinoid/trastuzumab combinations.维甲酸联合曲妥珠单抗或他莫昔芬治疗乳腺癌细胞的抗肿瘤作用:维甲酸/曲妥珠单抗联合诱导细胞凋亡。
Breast Cancer Res. 2010;12(4):R62. doi: 10.1186/bcr2625. Epub 2010 Aug 9.
Acta Neurochir (Wien). 1982;64(3-4):199-213. doi: 10.1007/BF01406053.
4
Significance of aromatase activity in human breast cancer.芳香化酶活性在人类乳腺癌中的意义。
Cancer Res. 1982 Aug;42(8 Suppl):3365s-3368s.
5
Relationships between steroid receptor and epithelial cell proliferation in benign fibrocystic disease of the breast.乳腺良性纤维囊性疾病中类固醇受体与上皮细胞增殖之间的关系。
Cancer. 1982 Jun 15;49(12):2534-6. doi: 10.1002/1097-0142(19820615)49:12<2534::aid-cncr2820491221>3.0.co;2-j.
6
Steroid receptor proteins in human meningiomas.人类脑膜瘤中的类固醇受体蛋白。
Cancer. 1982 Feb 15;49(4):633-6. doi: 10.1002/1097-0142(19820215)49:4<633::aid-cncr2820490404>3.0.co;2-4.
7
Menstrual cycle-dependent variations of breast cyst fluid proteins and sex steroid receptors in the normal human breast.正常人类乳腺中乳腺囊肿液蛋白质和性类固醇受体的月经周期依赖性变化。
Cancer. 1983 Apr 1;51(7):1297-302. doi: 10.1002/1097-0142(19830401)51:7<1297::aid-cncr2820510720>3.0.co;2-z.
8
Prognostic factors in primary breast cancer.原发性乳腺癌的预后因素。
Breast Cancer Res Treat. 1983;3 Suppl:S69-72. doi: 10.1007/BF01855130.
9
Sex steroid receptors in human meningiomas.人类脑膜瘤中的性类固醇受体
Clin Neuropharmacol. 1984;7(4):320-4. doi: 10.1097/00002826-198412000-00008.
10
[Steroid hormone receptors in benign breast diseases].
Pathol Biol (Paris). 1983 Nov;31(9):767-73.